Fully revised, this second edition presents trainees with the latest guidance on preparation for OSCE examinations. Comprised of fourteen chapters, the book covers all the key learning points and provides an understanding of the basic concepts behind the OSCE and advice on appropriate response. The new edition includes many new cases and covers numerous topics including genetics, neurology, drugs and vaccines, neonatology, cardiovascular system, endocrinology and much more. Enhanced by nearly 240 clinical photographs and illustrations, the book also includes multiple choice questions to help students prepare for MRCPCH and US Specialty Board examinations. Key points Fully revised, new edition providing guidance on preparation for OSCE examinations Includes multiple choice questions to help revision for MRCPCH and US Specialty Board exams Enhanced by nearly 240 clinical photographs and illustrations Previous edition (9789350251553) published in 2010

This book covers innovative breakthroughs in additive manufacturing processes used for biomedical engineering. More and more, 3D printing is selected over traditional manufacturing processes, especially for complex designs, because of the many advantages such as fewer restrictions, better production cost savings, higher quality control, and accuracy. Current challenges and opportunities regarding material, design, cost savings, and efficiency are covered along with an outline of the most recent fabrication methods used for converting biomaterials into integrated structures that can fit best in anatomy while still obtaining the necessary architecture, mechanical reliability, biocompatibility, and anti-bacterial characteristics needed. Additional chapters will also focus on selected areas of applications such as bionics, affordable prostheses, implants, medical devices, rapid tooling, and drug delivery. Additive Manufacturing Processes in Biomedical Engineering: Advanced Fabrication Methods and Rapid Tooling Techniques acts as a first-hand reference for commercial manufacturing organizations which are mimicking tissue organs by using additive manufacturing techniques. By capturing the current trends of today's manufacturing practices this book becomes a one-stop resource for manufacturing professionals, engineers in related disciplines, and academic researchers.

Interim remedies and provisional measures are a critical component of civil/commercial litigation and arbitration. The objective of this book is to set out not just the law and practice in relation to the primary interim remedies and preservation measures available in England & Wales and China, but also to provide the comparative analysis between the two jurisdictions concerning these interim measures. The system for interim remedies in England & Wales is well-established, but preservation measures in China are a work in progress and many differences exist between the two legal systems, both in terms of theory and practice. For example, China does not recognise the general concept of interim measures, if looked at from the English law point of view, though it does have similar concepts of Property preservation, evidence preservation and behaviour preservation. China has recently adopted Chinese Civil Code 2020 and in writing this book the authors have incorporated all the relevant elements from the new Code. There is no equivalent of Practice Directions in China, and this book provides provide much needed clarity on this area, drawing together the law and guidance which is presently scattered across numerous local courts in the different provinces. This is an important book that is likely to have a significant impact on existing scholarship regarding interim remedies in England, Wales and China, and be of interest of all parties involved in cross-border litigation. Its readership will include industry professionals, academics, policy-makers and government officials.

Oracle e-Business Suite Payroll R12 is written for new and intermediate users, key-users and administrators. It focuses on your role in an Oracle eBS-environment and explains the Concepts, describes the main Screens, gives Step-by-Step instructions with navigation paths and has a Glossary and FAQ-list. All chapters have Questions and Answers. The book has six chapters, 81 pages and has lots of screenshots and illustrations. With this book you learn the main concepts like: Assignment and Consolidation Sets, Defining a new Payroll, running a Payroll run, Balance Feeds and Balance Dimension, Batch Element Entry, Conversion Rate Types, Costing, Reversing and Advance pay Period. And the most important flows including their steps are also described for you, like: Reverse a Payroll, Voiding a Check, Transfer to GL Flow and Setting Up the Payslip. This is just a small list of all the concepts, screens and flows described in this book. What do eBS users think about these books? "Very well structured and easy to follow, even for beginners. " John M. McNamara - Wokingham Borough Council "Highly informative and exemplary, hats off." Sunil Sunder Rao - Apps DBA "I am really happy that I found these books." Peter Lung - Consultant

The resistance of malaria parasites to widely used drugs prompted an upsurge in the development of new drugs with novel mechanism of action, and re- evaluation of the existing drugs to overcome the resistance problem. A number of new potential target pathways have already been identified and efforts to develop lead compounds for these putative targets hopefully will allow treatment of malaria infections in a uniform sustained way. Considerable research efforts were directed in the areas of chloroquine drug resistance reversal agents. Careful development of some bisquinolines, which are free of toxic side effect, 4-anilinoquinolines and modified chloroquine analogs may be helpful to obtain drug candidates that inhibit the growth of chloroquine sensitive and resistant parasites. In the past several years, new structural classes of antimalarial agents, target based antimalarial agents, iron chelators have made some interesting and promising lead molecules available for further optimization to provide compounds for clinical development.